Biocentury
In response to the urgent need for information about the coronavirus crisis, BioCentury’s coverage of the policy developments, scientific advances, and progress on countermeasures for free. This collection is frequently updated as research develops. Biocentury is internationally recognized as the leading provider of value-added information, analysis and data for biotechnology and pharmaceutical companies, investors, academia and government on the strategic issues essential to the formation, development and sustainability of life science ventures